GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75N91022F00005LEIDOS BIOMEDICAL RESEARCH INC

Overview

Award facts

Net obligations
$11.53M
$11,527,609of $11.53M potential value
Outlays (paid to date)
$7.13M
$7.13M paid of $11.53M obligated$7,126,985
Period of performance
Mar 4, 2022 to Jul 30, 2030
Ends in about 4 years
Modifications
6
Latest action Jul 30, 2025
Contract type
Delivery order
PIID 75N91022F00005

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

NIAID VRC - PREMISE - PANDEMIC RESPONSE REPOSITORY THROUGH MICROBIAL AND IMMUNOLOGIC SURVEILLANCE AND EPIDEMIOLOGY

Dates and value

Award date
Signed on Mar 4, 2022
Potential end of performance
Jul 29, 2030
Current value
$11,527,609Base and exercised options
Potential value (if all options are exercised)
$11,527,609
Parent contract vehicle
75N91019D00024 (IDC, single award) — 185 orders recorded under it

Obligations by fiscal year of action

  • FY2025: $885,777
  • FY2023: $5,244,810
  • FY2022: $5,397,022

Total across 3 fiscal years: $11,527,609

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 30, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationFREDERICK, MD
UEIHV8BH9BPG8Y9
CAGE code3LYK6
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyLEIDOS HOLDINGS, INC.

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885); Nih royaltiesProgram activities075-0140, 075-0849, 075-0885, 075-3966Federal accounts (agency financial reports)

Place of performance

Place of performance
Frederick, Maryland 21702-0001
Congressional district (place of performance)
MD-06As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Not reported
Contract pricing
Cost plus fixed feeU

Solicitation and notices

Solicitation ID
NIAID-VRC-22-0042(as reported)
Solicitation date
Jan 14, 2022

Contract details

Subcontracting plan
Individual subcontract planF
Certified cost or pricing data
Yes
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Mar 4, 2022Base obligation at award: $2,185,220
Latest action
Jul 30, 2025 — Option exercisedModification P00006; obligation change +$885,777
Latest substantive action
Jul 30, 2025 — Option exercisedModification P00006; obligation change +$885,777
Actions by type
  • Base award1
  • Other administrative action4
  • Option exercised2
7 actions recorded, Mar 4, 2022 to Jul 30, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$885,777
Latest action: change in base and all options
-$8,925,384

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
Environmentally preferableF
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
National Institutes Of Health7529
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N910
Transactions recorded under this award key
7

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2020/2024-0885-000
  • 075-2021/2023-3966-000
  • 075-2022/2022-0849-000
  • 075-2022/2022-0885-000
  • 075-2023/2023-0885-000
  • 075-2023/2025-3966-000
Show all 9 accounts
  • 075-2025/2025-0849-000
  • 075-X-0140-000
  • 075-X-0849-000
Object classes
  • 25.2: Other services from non-Federal sources
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • L: Emergency P.L. 116-123
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
  • V: Non-emergency P.L. 117-2
COVID-19 supplemental obligations
$2,344,095
COVID-19 supplemental outlays
$1,961,744